<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
"http://www.w3.org/TR/html4/strict.dtd">
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>
	<!-- CSS
  ================================================== -->
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/layout.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/content.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/print.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/font-awesome.css">	

	<!-- Basic Page Needs
  ================================================== -->
    <script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/jquery-1.8.3.min.js" type="text/javascript"></script>
    <script type="text/x-mathjax-config">
	MathJax.Hub.Config({
	  "HTML-CSS": { linebreaks: { automatic: true } },
	         SVG: { linebreaks: { automatic: true } }
	});
	</script>
    <script type="text/javascript" src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
	<meta charset="utf-8">
	<title>Musculoskeletal System</title>
	<meta name="description" content="Course Notes for Musculoskeletal System">
	<meta name="author" content="Kevan Lu">
	<meta name="robots" content="noindex,nofollow"/>
	
	<!-- Mobile Specific Metas
  ================================================== -->
	<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0"/>

	<script>
	  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
	  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
	  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
	  })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

	  ga('create', 'UA-40381402-3', 'auto');
	  ga('send', 'pageview');
	</script>

	<!-- Favicons
	================================================== -->
	<link rel="shortcut icon" href="https://dl.dropboxusercontent.com/u/157117/Class%20References/favicon.png" type="image/png">

	<!-- iOS Icons
	================================================== -->
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-iphone.png" rel="apple-touch-icon"/>
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-ipad.png" rel="apple-touch-icon" sizes="76x76" />
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-iphone-retina.png" rel="apple-touch-icon" sizes="120x120"/>
	<link href="https://dl.dropboxusercontent.com/u/157117/notes/resources/images/icon-ipad-retina.png" rel="apple-touch-icon" sizes="152x152" />
</head>
<body>
    <div id="home-overlay">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<div id="header-search-icon"><a id="header-search-button"><i class="fa fa-search"></i></a></div>
</div>
<div id="header-search-bar">
	<form class="search" action="http://www.schulichnotes.com/musculoskeletal/search.html">
	<div><input type="text" value="Search Musculoskeletal System" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	</form>
</div>
<div id="overlay"><h1><a style="border:none;" href="http://www.schulichnotes.com/musculoskeletal">Musculoskeletal System</a></h1></div>
    <div class="sidebar-background"></div>
    <div class="sidebar">
        <!-- Displays a Search Bar-->
<div class="search-wrapper">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<form class="search" action="http://www.schulichnotes.com/musculoskeletal/search.html">
	<div style="float: left;"><input type="text" value="Search Musculoskeletal System" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	<div style="float: left;"><input type="button" id="tipue_search_button" onclick="this.form.submit();"></div>
	<div style="clear: left;"></div>
	</form>
</div>

<div class="course-index">
	<a href="http://www.schulichnotes.com/musculoskeletal">Musculoskeletal System</a>
</div>

        <nav>	
	<li class="week">Week 1</li>
	<ul>
		<li class="day">Monday, January 19</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/19/intro-msk.html">Introduction to the Musculoskeletal System</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/19/concepts-musculoskeletal-medicine.html">Concepts in Musculoskeletal Medicine</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/19/approach-spine.html">Approach to the Spine</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/19/anatomy-spine.html">Anatomy of the Spine</a></li></ul>
		<li class="day">Tuesday, January 20</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/20/approach-low-back-pain.html">Approach to Low Back Pain</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/20/imaging-low-back-pain-radiculopathy.html">Imaging with Low Back Pain &amp; Radiculopathy</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/20/injections-treatment-low-back-pain.html">Injections in the Treatment of Low Back Pain</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/20/anatomy-lab-back-spine.html">Anatomy Lab &ndash; Back and Spine</a></li></ul>
		<li class="day">Wednesday, January 21</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/21/anatomy-shoulder.html">Anatomy of the Shoulder</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/21/approach-shoulder.html">Approach to the Shoulder</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/21/anatomy-lab-posterior-shoulder.html">Anatomy Lab &ndash; Posterior Shoulder</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/21/anatomy-lab-pec-axilla.html">Anatomy Lab &ndash; Pec/Axilla</a></li></ul>
		<li class="day">Thursday, January 22</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/22/brachial-plexus.html">The Brachial Plexus</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/22/exercise-physiology.html">Exercise Physiology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/22/anatomy-lab-brachial-plexus.html">Anatomy Lab &ndash; Brachial Plexus</a></li></ul>
		<li class="day">Friday, January 23</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/23/anatomy-arm.html">Anatomy of the Arm</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/23/anatomy-forearm.html">Anatomy of the Forearm</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/23/approach-arm-elbow.html">Approach to the Arm and Elbow</a></li></ul>
	</ul>
	<li class="week">Week 2</li>
	<ul>
		<li class="day">Monday, January 26</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/26/case-week-brachial-plexus.html">Case of the Week &ndash; Brachial Plexus Injury</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/26/nerve-injuries.html">Nerve Injuries</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/26/nerve-surgery-reconstruction.html">Nerve Surgery &amp; Reconstruction</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/26/anatomy-lab-anterior-forearm.html">Anatomy Lab &ndash; Anterior Forearm</a></li></ul>
		<li class="day">Tuesday, January 27</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/27/anatomy-hand.html">Anatomy of the Hand</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/27/work-injuries-wsib.html">Workplace Injuries and WSIB</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/27/anatomy-lab-posterior-forearm.html">Anatomy Lab &ndash; Posterior Forearm</a></li></ul>
		<li class="day">Wednesday, January 28</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/28/approach-arm-wrist-hand.html">Approach to the Arm, Wrist & Hand</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/28/msk-infections.html">MSK Infections</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/28/anatomy-lab-hand.html">Anatomy Lab &ndash; Hand</a></li></ul>
		<li class="day">Thursday, January 29</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/29/fractures-complications.html">Fractures &amp; Complications</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/29/fracture-imaging.html">Fracture Imaging</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/29/small-group-fractures.html">Fractures Small Group</a></li></ul>
		<li class="day">Friday, January 30</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/30/pharmacology-arachidonic-acid-derivatives.html">Pharmacology of Arachidonic Acid Deriatives &ndash; NSAIDs</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/01/30/cervical-soft-tissue-injuries.html">Cervical Soft Tissue Injuries</a></li></ul>
	</ul>
	<li class="week">Week 3</li>
	<ul>
		<li class="day">Monday, February 2</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/02/anatomy-lab-posterior-thigh.html">Anatomy Lab &ndash; Posterior Thigh</a></li></ul>
		<li class="day">Tuesday, February 3</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/03/pccm-week-1-upper-limb.html">PCCM Week 1 &ndash; Upper Limb</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/03/approach-hip.html">Approach to the Hip</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/03/anatomy-lab-anterior-medial-thigh.html">Anatomy Lab &ndash; Anterior &amp; Medial Thigh</a></li></ul>
		<li class="day">Wednesday, February 4</li>
		<ul></ul>
		<li class="day">Thursday, February 5</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/05/anatomy-lab-leg-knee.html">Anatomy Lab &ndash; Leg &amp; Knee</a></li></ul>
		<li class="day">Friday, February 6</li>
		<ul></ul>
	</ul>
	<li class="week">Week 4</li>
	<ul>
		<li class="day">Monday, February 9</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/09/anatomy-lab-foot-ankle.html">Anatomy Lab &ndash; Foot &amp; Ankle</a></li></ul>
		<li class="day">Tuesday, February 10</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/10/pediatric-orthopedics-1.html">Pediatric Orthopedics I</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/10/pediatric-orthopedics-2.html">Pediatric Orthopedics II</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/10/child-health-small-groups-child-limp.html">Child Health Small Groups &ndash; Limp</a></li></ul>
		<li class="day">Wednesday, February 11</li>
		<ul></ul>
		<li class="day">Thursday, February 12</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/12/soft-tissue-injury-small-groups.html">Soft Tissue Injuries Small Group</a></li></ul>
	</ul>
	<li class="week">Week 5</li>
	<ul>
		<li class="day">Tuesday, February 17</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/17/acute-monoarthritis.html">Acute Monoarthritis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/17/chronic-monoarthritis.html">Chronic Monoarthritis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/17/small-group-monoarthritis.html">Monoarthritis Small Group</a></li></ul>
		<li class="day">Wednesday, February 18</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/18/acute-polyarthritis.html">Acute Polyarthritis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/18/rheumatoid-arthritis.html">Rheumatoid Arthritis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/18/rheumatology-labs.html">Rheumatology Labs</a></li></ul>
		<li class="day">Thursday, February 19</li>
		<ul></ul>
		<li class="day">Friday, February 20</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/20/connective-tissue-disorders-1.html">Connective Tissue Disorders I</a></li></ul>
	</ul>
	<li class="week">Week 6</li>
	<ul>
		<li class="day">Monday, February 23</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/23/DMARDs-biologics.html">DMARDs &amp; Biologics</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/23/small-groups-polyarthritis.html">Polyarthritis Small Group</a></li></ul>
		<li class="day">Tuesday, February 24</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/24/rheumatology-review-jeopardy.html">Rheumatology Review Jeopardy</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/24/msk-clinical-review.html">MSK Clinical Review</a></li></ul>
		<li class="day">Wednesday, February 25</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/25/soft-tissue-tumours.html">Soft Tissue Tumours</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/25/bone-tumours.html">Bone Tumours</a></li><li class="lecture"><a href="http://www.schulichnotes.com/musculoskeletal/2015/02/25/small-group-bone-tumour-pathology.html">Bone Tumour Pathology Small Group</a></li></ul>
	</ul>
</nav>
    </div>
    <div class="content-offset">
        <div class="content-background"></div>
        <div class="content">
            <div class="single post">
                <!-- Post Layout -->
                <div class="title"><h1>Pharmacology of Arachidonic Acid Deriatives &ndash; NSAIDs</h1></div>
                <info datetime="2015-01-30">
                    <span class="author"><a href="http://www.schulichnotes.com/about.html#kevanlu">Kevan Lu</a></span>
                    <span class="date">Friday, January 30, 2015</span>
                </info>
                <div class="body"><h2 id="lecture-objectives"><strong>Lecture Objectives</strong></h2>
<ol>
  <li>To understand the basis for inflammation particularly as it pertains to arachidonic acid metabolism and the enzymatic formation of pro- inflammatory eicosanoids (prostaglandins).</li>
  <li>To understand the mechanistic bases for the therapeutic and toxic effects of NSAIDs.</li>
</ol>

<h2 id="inflammation"><strong>Inflammation</strong></h2>
<ul>
  <li>Inflammation is a reaction in the tissues to infection, irritation or injury.</li>
  <li>It’s characterized by the 5 cardinal signs:
    <ul>
      <li><em>Rubor</em> (redness).</li>
      <li><em>Calor</em> (heat).</li>
      <li><em>Dolor</em> (pain).</li>
      <li><em>Tumor</em> (swelling).</li>
      <li><em>Functio leasa</em> (loss of function).</li>
    </ul>
  </li>
  <li>Functionally speaking, inflammation is a <em>defense</em> mechanism against infection and tumours; it brings immune cells to the vicinity of an injurious process.
    <ul>
      <li>It’s also important in repair and regeneration after an injury.</li>
    </ul>
  </li>
</ul>

<h2 id="proposed-mediators-of-inflammation"><strong>Proposed Mediators of Inflammation</strong></h2>
<ul>
  <li>There are many proposed mediators of inflammation, including clotting factors, bradykinin, complement proteins, cytokines, etc.</li>
  <li>The ones that are relevant for today’s lecture are the <em>arachidonic acid metabolites</em> (eicosanoids).
    <ul>
      <li>Cyclooxygenase products → <em>prostaglandins</em>.</li>
      <li>Lipoxygenase products → <em>leukotrienes</em>.</li>
      <li>Epoxygenase products → <em>epoxides</em>.</li>
    </ul>
  </li>
</ul>

<h1 id="prostaglandins">Prostaglandins</h1>
<hr />

<ul>
  <li>Of these, prostaglandins are the target of NSAIDs.
    <ul>
      <li>They’re 20C fatty acid derivatives, and modulate a number of key biological processes, including gut integrity and renal function.</li>
    </ul>
  </li>
  <li><em>Prostaglandins are produced from Arachidonic Acid</em>:
    <ul>
      <li>Arachidonic acid is a polyunsaturated fatty acid (cis-5,8,11,14-eicosatetraenoic acid).</li>
      <li>Arachidonic acids are located in <em>cell membranes</em>, particularly in the phospholipids.</li>
      <li>They can either be derived directly from our diet, or can be synthesized from linoleic acid.</li>
    </ul>
  </li>
</ul>

<p><img src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/mo7_oqo3.png" /></p>

<ul>
  <li><strong>Effects of Prostaglandins</strong>:
    <ul>
      <li><em>Gut integrity</em> (cytoprotection of gastric mucosa) → this is why long-term NSAID use can cause gastric ulcers.</li>
      <li><em>Haemostasis</em></li>
      <li><em>Vasoconstriction</em></li>
      <li><em>Vasodilation</em></li>
      <li><em>Renal homeostasis</em> → recall that prostaglandins dilate the afferent arterioles, so NSAIDs block them.
        <ul>
          <li>We saw this in <a href="http://www.schulichnotes.com/genitourinary/2014/04/08/gfr-physiology.html">GFR Physiology</a>.</li>
          <li>This was also why giving an ACEI with an NSAID could lead to a dramatic drop in the GFR.</li>
        </ul>
      </li>
      <li><em>Labour and parturition</em> (giving birth) → this is why misoprostol (a prostaglandin analogue), is an abortifacient.</li>
    </ul>
  </li>
  <li>Different prostaglandins mediate these different effects, depending on their distribution in your body.</li>
</ul>

<h1 id="cyclooxygenases">Cyclooxygenases</h1>
<hr />

<ul>
  <li><strong>Cyclooxygenases</strong> → <em>convert ARACHIDONIC ACIDS into PROSTAGLANDINS</em> (as well as Thromboxanes and Prostacyclins).</li>
  <li>There are 2 isoforms that have been identified: COX-1 and COX-2.
    <ul>
      <li><em>COX-1</em> → constitutively expressed.</li>
      <li><em>COX-2</em> → inducible.</li>
    </ul>
  </li>
</ul>

<h2 id="cyclooxygenase-1-cox-1">1. <strong>Cyclooxygenase 1 (COX-1)</strong></h2>
<ul>
  <li>Also known as <em>Prostaglandin-endoperoxide synthase 1</em></li>
  <li><em>Constitutively expressed.</em></li>
  <li>Expressed in platelets, gut and kidney
    <ul>
      <li>In <em>platelets</em>, converts AA to TXA2.</li>
      <li>In the <em>gut</em>, converts AA to cytoprotective prostaglandins.</li>
    </ul>
  </li>
  <li>Recall from <a href="http://www.schulichnotes.com/blood">Blood</a> that the mechanism of ASA was to block COX-1 mediated conversion of AA to TXA2 in the platelets!</li>
  <li>Recall from <a href="http://www.schulichnotes.com/gastrointestinal">Digestive System &amp; Nutrition</a> that the blocking of cytoprotective prostaglandins by NSAIDs could lead to PUD.</li>
  <li>The activity of COX-1 can be induced under certain conditions such as inflammation.</li>
</ul>

<h2 id="cyclooxygenase-2-cox-2">2. <strong>Cyclooxygenase 2 (COX-2)</strong></h2>
<ul>
  <li>Also known as <em>Prostaglandin-endoperoxide synthase 1</em></li>
  <li><em>Inducible</em>; induction is enhanced by <i>inflammation.</i></li>
  <li>Present in synovial membranes in arthritis, although it also seems to have a physiological role.</li>
</ul>

<h1 id="non-steroidal-anti-inflammatory-drugs-nsaids">Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)</h1>
<hr />

<ul>
  <li>Since they play a key role in inflammation and inflammation-mediated pain, prostaglandins are an attractive therapeutic target.</li>
  <li>The classic application of this is with <strong>NSAIDs</strong>, drugs which inhibit pain and inflammation by inhibition of prostaglandin synthesis.</li>
  <li><em>There are 3 classes of NSAIDs</em>
    <ol>
      <li><em>Salicylates</em>.</li>
      <li><em>Traditional NSAIDs</em>.</li>
      <li><em>COX-2 Selective Drugs</em>.</li>
    </ol>
  </li>
</ul>

<h2 id="salicylates">1. <strong>Salicylates</strong></h2>

<p><img class="right" src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/1tcar97h.png" /></p>

<ul>
  <li><em>Example</em> → <strong>Aspirin</strong> <em>(acetylsalicylic acid)</em>.</li>
  <li>ASA <i>irreversibly</i> inhibits COX-1 and alters COX-2 activity to preferentially synthesize lipoxins (anti-inflammatory) instead of prostinoids (pro-inflammatory).
    <ul>
      <li>Because it binds irreversibly, although its half life is very short, it’s biologic effect is quite long.</li>
    </ul>
  </li>
  <li><strong>Pharmacology of ASA</strong>:
    <ul>
      <li><em>Absorption</em> → readily absorbed in the small intestine.</li>
      <li><em>Distribution</em> → 50-80% protein bound, VD 0.2 L/kg.</li>
      <li><em>Metabolism</em> → primarily <i>hepatic</i>, metabolism can easily be saturated with supra-therapeutic doses (bad).</li>
      <li><em>Excretion</em> → renally excreted.</li>
    </ul>
  </li>
  <li><strong>Indications</strong>:
    <ul>
      <li>Analgesic, antipyretic, anti-inflammatory (high-dose ASA), anti-thrombotic (low-dose ASA).</li>
    </ul>
  </li>
  <li><strong>Contraindications</strong>:
    <ul>
      <li>Hypersensitivity to NSAIDs.</li>
      <li>Children with viral illness (risk of <em>Reye’s Syndrome</em>, which causes fatty liver and cerebral edema).</li>
      <li>Reye’s syndrome is potentially fatal, so don’t give aspirin to sick children!</li>
    </ul>
  </li>
  <li><strong>Adverse Drug Reactions</strong>:
    <ul>
      <li><em>GI bleeding</em>.</li>
      <li>Tinnitus (in high doses).</li>
      <li>Hypersenstivity</li>
      <li>Prolonged bleeding.</li>
    </ul>
  </li>
  <li><strong>Toxicity</strong> → <em>our body’s conjugation systems rapidly saturate.</em>
  <img class="right" src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/1a2ihebl.png" />
    <ul>
      <li>Drugs that must be conjugated in order to be excreted generally have this behaviour, of rapid saturation.</li>
      <li>As a result, the kinetics change quickly from first order to zero order, resulting in substantial increases in serum drug concentration after a certain point.</li>
      <li>ASA toxicity associated with significant mortality (2% with an acute overdose, 25% with a chronic overdose).</li>
    </ul>
  </li>
</ul>

<h2 id="traditional-nsaids">2. <strong>Traditional NSAIDs</strong></h2>
<ul>
  <li><em>Example</em> → <strong>Ibuprofen</strong>.</li>
  <li>Developed because aspirin proved to be so useful and popular, so people began to look for other drugs (especially once the side effects of steroids became better known).</li>
  <li>Ibuprofen is a proprionic acid derivative, with an efficacy and adverse effects profile similar to ASA.
    <ul>
      <li><strong>However, there’s NO CONNECTION between non-ASA NSAIDs and Reye’s Syndrome</strong>.</li>
      <li>As a result, Ibuprofen, and other non-aspirin NSAIDs are safe to use with sick children!</li>
    </ul>
  </li>
  <li><strong>Examples of traditional NSAIDs</strong>:
    <ul>
      <li><em>Ibuprofen</em></li>
      <li>Indomethicin</li>
      <li>Naproxen</li>
      <li>Diclofenac</li>
      <li>Ketorolac</li>
    </ul>
  </li>
  <li><strong>Problems with Traditional NSAIDs</strong>:
    <ol>
      <li><em>Afferent arteriolar vasoconstriction</em>:
        <ul>
          <li>NSAIDs reduce GFR, so they’re very bad in patients with renal damage, or who are already dehydrated and have a low GFR.</li>
        </ul>
      </li>
      <li><em>GI Bleeding</em>
        <ul>
          <li>Can cause PUD (typically gastric ulcers; recall that <i>H. pylori</i> is the more common cause of duodenal ulcers).</li>
          <li>In Canada, about 400 deaths/year, and 4000 hospitalizations arise due to GI bleeding.</li>
          <li>As a result, some people have opted to give patients a PPI or H2 antagonist concomitantly, as protection.</li>
          <li>This also prompted research into more selective prostaglandin inhibitors → the <em>COX-2 inhibitors</em>.</li>
        </ul>
      </li>
    </ol>
  </li>
</ul>

<h2 id="cox-2-inhibitors">3. <strong>COX-2 Inhibitors</strong></h2>

<p><img class="med-right" src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/gzwr4rrn.png" /></p>

<ul>
  <li>Recall that COX-1 was constitutively expressed, while COX-2 was inducible.</li>
  <li>The idea was thus to produce a <em>COX-2 specific inhibitor</em>, which would avoid some of the side-effects caused by constitutive cyclooxygenase inhibition.</li>
  <li><strong>Examples of COX-2 Selective Inhibitors</strong>:
    <ul>
      <li><em>Rofecoxib</em> (Vioxx)</li>
      <li><em>Celecoxib</em> (Celebrix)</li>
      <li>Valdecoxib (Bextra)</li>
    </ul>
  </li>
</ul>

<p><img class="right" src="https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/6qum-nvl.png" /></p>

<ul>
  <li><em>However, it was found amidst a great deal of media controversy that Vioxx <strong>increased the risk of MIs</strong></em>.
    <ul>
      <li>There are a number of competing theories as to why this might be the case:
        <ul>
          <li>Selective inhibition of PGI2 (prostacyclin) without TXA2 inhibition (which is COX-1 specific) might have lead to increased thrombosis.</li>
          <li>COX-2 may produce cardioprotection following ischemia.</li>
          <li>COX-2 inhibitors may cause hypertension.</li>
        </ul>
      </li>
      <li>But regardless of the cause, Vioxx and Bextra were taken off the market.</li>
      <li><em>The only remaining COXIB is Celecoxib (Celebrix)</em>.</li>
    </ul>
  </li>
  <li>Health Canada now recommends that COX-2 selective inhibitors can still be used, but patients on it must be carefully selected and monitored.</li>
</ul>

<blockquote>
  <h4 id="summary-of-nsaids"><strong>Summary of NSAIDs</strong></h4>
  <ol>
    <li><strong>Salicylates</strong> (eg. <em>ASA</em>):
      <ul>
        <li>These have diverse uses, including as an anti-thrombotic agent.</li>
        <li>However, they carry the risk of <em>Reye’s syndrome</em> is used in children with viral illnesses.</li>
        <li>They also carry the risk of GI bleeding and reduction of renal blood flow.</li>
      </ul>
    </li>
    <li><strong>Traditional NSAIDs</strong> (eg. <em>Ibuprofen</em>)
      <ul>
        <li>These don’t have the risk of Reye’s syndrome.</li>
        <li>However, they still carry the risk of GI-bleeding, and afferent arteriolar vasoconstriction.</li>
      </ul>
    </li>
    <li><strong>COX-2 Inhibitors</strong> (eg. <em>Celecoxib</em>)
      <ul>
        <li>These were developed to avoid the risk of GI bleeding.</li>
        <li>However, it was found that one of them (infamously, Vioxx), resulted in an increased risk of MIs.</li>
      </ul>
    </li>
  </ol>
</blockquote>

<h1 id="acetaminophen">Acetaminophen</h1>
<hr />

<ul>
  <li><strong>Acetaminophen</strong> (aka. <em>Paracetamol</em> outside of Canada and the US) is an analgesic-antipyretic.
    <ul>
      <li><em>Trade name</em>: <strong>Tylenol</strong>.</li>
      <li>Acetaminophen is <em>less potent than NSAIDs</em>, but also carries <em>fewer side effects</em>.</li>
      <li><em>Acetaminophen has no anti-inflammatory effects</em>:
        <ul>
          <li><i>Hence, it’s not an NSAID</i>.</li>
          <li>It’s mechanism of action is still under debate; some believe that it inhibits a ‘3rd cyclooxygenase’ called COX-3; others believe that it blocks COX (hehe), but also blocks their inflammatory activity.</li>
        </ul>
      </li>
    </ul>
  </li>
  <li><strong>Pharmacology of Acetaminophen</strong>:
    <ul>
      <li><em>Absorption</em> → excellent GI absorption.</li>
      <li><em>Distribution</em> → widely distributed, VD 1.0 L/kg.</li>
      <li><em>Metabolism</em> → metabolized in therapeutic doses by glucuronic acid conjugation.</li>
      <li><em>Excretion</em> → metabolites eliminated in the urine.</li>
    </ul>
  </li>
  <li><strong>Indications</strong> → analgesia, anti-pyretic.
    <ul>
      <li><em>Not an anti-inflammatory</em>.</li>
    </ul>
  </li>
  <li><strong>Contraindications</strong>:
    <ul>
      <li>Hypersensitivity to acetaminophen.</li>
      <li>Use with caution in the presence of liver disease or alcoholism.</li>
    </ul>
  </li>
  <li><strong>Adverse Drug Reactions</strong>:
    <ul>
      <li><em>Very infrequent</em>.</li>
      <li>GI discomfort is probably the most common.</li>
    </ul>
  </li>
  <li><strong>Drug Toxicity</strong>
    <ul>
      <li><em>Conjugation pathways are easily saturated</em>.</li>
      <li>After this point, metabolism switches to oxidative (Phase I) pathways, which result in a more <em>toxic metabolite</em>.</li>
      <li>This can result in <strong>hepatic injury</strong>, and may progress to hepatic failure.</li>
      <li><em>Currently the most common cause of acute liver failure in the UK and US</em>.</li>
      <li><em>N-acetylcysteine (NAC)</em> can be used to bind these toxic metabolites, and treat this hepatic injury.</li>
    </ul>
  </li>
</ul>

<blockquote>
  <h4 id="summary-of-acetaminophen"><strong>Summary of Acetaminophen</strong></h4>
  <ul>
    <li>Can be used as an <em>analgesic or anti-pyretic</em>, but it has <strong>no anti-inflammatory activity</strong>.</li>
    <li>Hence, it’s less potent than NSAIDs, but also carries <em>fewer side effects</em> or adverse drug reactions.</li>
    <li>However <strong>overdose leads to hepatic toxicity</strong>; Acetaminophen overdose is the most common cause of acute liver failure.</li>
  </ul>
</blockquote>
                
                </div>
            </div>
            <div class="pagination">
                <div style="width:50%; float:left;">
                     
                        <a class="newer" href="http://www.schulichnotes.com/musculoskeletal/2015/01/29/small-group-fractures.html"><i class="fa fa-angle-left"></i> Fractures Small Group</a> 
                     
                </div>
                <div style="width:50%; float:right;">
                     
                        <a class="older" href="http://www.schulichnotes.com/musculoskeletal/2015/01/30/cervical-soft-tissue-injuries.html">Cervical Soft Tissue Injuries <i class="fa fa-angle-right"></i></a> 
                     
                </div>
            </div>
        </div>
    </div>
    <script src="http://www.schulichnotes.com/musculoskeletal/index.js" type="text/javascript"></script>
<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/search.css">	
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/tipuesearch_set.js" type="text/javascript"></script>
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/tipuesearch.js" type="text/javascript"></script>
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/classie.js" type="text/javascript"></script>
<script>
var search = document.getElementById('header-search-icon');
var searchbar = document.getElementById('header-search-bar');
search.onclick = function(){classie.toggle(searchbar, 'search-bar-open');}
$(document).ready(function() {$('#tipue_search_input').tipuesearch();});
</script>
</body>
</html>